Eli Lilly announced a plan to widen access to its diabetes and obesity treatments by 2040. The story reports no sales or treatment results from the plan, so it does not change the company's outlook.
The access plan could help more people obtain Lilly's treatments. The article reports no change in sales, treatment use, or other business results. Most of the story discusses Hyde Amendment criticism, not Lilly.
Microsoft's Mayo Clinic partnership is mentioned as an earlier effort to build a health care AI model. The story reports no progress or results from it, so it does not change Microsoft's outlook.
Follow Eli Lilly and Company (LLY) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for LLY